Intravital FRET Imaging of Tumor Cell Viability and Mitosis during Chemotherapy

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Janssen, Aniek ^a,b   Beerling, Evelyne ^b   Medema, René ^a,b   van Rheenen, Jacco ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DOCETAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER TISSUE; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMAGING AND DISPLAY; IN VITRO STUDY; IN VIVO STUDY; INTRAVITAL IMAGING; MITOSIS; MOUSE; NONHUMAN; SINGLE DRUG DOSE; VALIDATION PROCESS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MICE; MITOSIS; TAXOIDS;

EID: 84877783194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064029     Document Type: Article

References (46)

1. Jordan MA, Wilson L, (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265.
2. Bissery MC, Nohynek G, Sanderink GJ, Lavelle F, (1995) Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. Anticancer Drugs 6: 339-355, 363-338.
3. Noguchi S, (2006) Predictive factors for response to docetaxel in human breast cancers. Cancer Sci 97: 813-820.
4. Davies AM, Lara PN Jr, Mack PC, Gandara DR, (2003) Docetaxel in non-small cell lung cancer: a review. Expert Opin Pharmacother 4: 553-565.
5. Nogales E, Wolf SG, Khan IA, Luduena RF, Downing KH, (1995) Structure of tubulin at 6.5 A and location of the taxol-binding site. Nature 375: 424-427.
6. Schiff PB, Fant J, Horwitz SB, (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277: 665-667.
7. Schiff PB, Horwitz SB, (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 77: 1561-1565.
8. Ringel I, Horwitz SB, (1991) Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83: 288-291.
9. Yvon AM, Wadsworth P, Jordan MA, (1999) Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell 10: 947-959.
10. Gascoigne KE, Taylor SS, (2008) Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111-122.
11. Brito DA, Rieder CL (2008) The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells. Cell Motil Cytoskeleton.
12. Shi J, Orth JD, Mitchison T, (2008) Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res 68: 3269-3276.
13. Ikui AE, Yang CP, Matsumoto T, Horwitz SB, (2005) Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy. Cell Cycle 4: 1385-1388.
14. Chen JG, Horwitz SB, (2002) Differential mitotic responses to microtubule-stabilizing and-destabilizing drugs. Cancer Res 62: 1935-1938.
15. Horwitz SB, (1994) Taxol (paclitaxel): mechanisms of action. Ann Oncol 5Suppl 6: S3-6.
16. Orth JD, Kohler RH, Foijer F, Sorger PK, Weissleder R, et al. (2011) Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics. Cancer Res 71: 4608-4616.
17. Milas L, Hunter NR, Kurdoglu B, Mason KA, Meyn RE, et al. (1995) Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol 35: 297-303.
18. Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, et al. (1996) Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 88: 1308-1314.
19. Symmans WF, Volm MD, Shapiro RL, Perkins AB, Kim AY, et al. (2000) Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment. Clin Cancer Res 6: 4610-4617.
20. Beerling E, Ritsma L, Vrisekoop N, Derksen PW, van Rheenen J, (2011) Intravital microscopy: new insights into metastasis of tumors. J Cell Sci 124: 299-310.
21. Zomer A, Beerling E, Vlug EJ, van Rheenen J, (2011) Real-time intravital imaging of cancer models. Clin Transl Oncol 13: 848-854.
22. Porter AG, Janicke RU, (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104.
23. Bins AD, van Rheenen J, Jalink K, Halstead JR, Divecha N, et al. (2007) Intravital imaging of fluorescent markers and FRET probes by DNA tattooing. BMC Biotechnol 7: 2.
24. Keese M, Offterdinger M, Tischer C, Girod A, Lommerse PH, et al. (2007) Quantitative imaging of apoptosis commitment in colorectal tumor cells. Differentiation 75: 809-818.
25. Keese M, Yagublu V, Schwenke K, Post S, Bastiaens P, (2010) Fluorescence lifetime imaging microscopy of chemotherapy-induced apoptosis resistance in a syngenic mouse tumor model. Int J Cancer 126: 104-113.
26. van der Wal J, Habets R, Varnai P, Balla T, Jalink K, (2001) Monitoring agonist-induced phospholipase C activation in live cells by fluorescence resonance energy transfer. J Biol Chem 276: 15337-15344.
27. Gurskaya NG, Verkhusha VV, Shcheglov AS, Staroverov DB, Chepurnykh TV, et al. (2006) Engineering of a monomeric green-to-red photoactivatable fluorescent protein induced by blue light. Nat Biotechnol 24: 461-465.
28. Kedrin D, Gligorijevic B, Wyckoff J, Verkhusha VV, Condeelis J, et al. (2008) Intravital imaging of metastatic behavior through a mammary imaging window. Nat Methods 5: 1019-1021.
29. Gligorijevic B, Kedrin D, Segall JE, Condeelis J, van Rheenen J (2009) Dendra2 photoswitching through the Mammary Imaging Window. J Vis Exp.
30. Ritsma L, Steller EJ, Beerling E, Loomans CJ, Zomer A, et al. (2012) Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Sci Transl Med 4: 158ra145.
31. van Munster EB, Gadella TW, (2005) Fluorescence lifetime imaging microscopy (FLIM). Adv Biochem Eng Biotechnol 95: 143-175.
32. Tighe A, Johnson VL, Albertella M, Taylor SS, (2001) Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep 2: 609-614.
33. Lengauer C, Kinzler KW, Vogelstein B, (1997) Genetic instability in colorectal cancers. Nature 386: 623-627.
34. Thompson SL, Compton DA, (2008) Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 180: 665-672.
35. Ritsma L, Ponsioen B, van Rheenen J, (2012) Intravital imaging of cell signaling in mice. Intravital 1.
36. Mitchison TJ, (2012) The proliferation rate paradox in antimitotic chemotherapy. Mol Biol Cell 23: 1-6.
37. Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, et al. (2012) Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21: 488-503.
38. Javeed A, Ashraf M, Riaz A, Ghafoor A, Afzal S, et al. (2009) Paclitaxel and immune system. Eur J Pharm Sci 38: 283-290.
39. Fitzpatrick FA, Wheeler R, (2003) The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents. Int Immunopharmacol 3: 1699-1714.
40. Janssen A, Medema RH, (2011) Mitosis as an anti-cancer target. Oncogene 30: 2799-2809.
41. Huszar D, Theoclitou ME, Skolnik J, Herbst R, (2009) Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev 28: 197-208.
42. Lok W, Klein RQ, Saif MW, (2010) Aurora kinase inhibitors as anti-cancer therapy. Anticancer Drugs 21: 339-350.
43. Janssen A, Kops GJ, Medema RH, (2009) Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci U S A 106: 19108-19113.
44. Tang YC, Williams BR, Siegel JJ, Amon A, (2011) Identification of aneuploidy-selective antiproliferation compounds. Cell 144: 499-512.
45. Smakman N, Veenendaal LM, van Diest P, Bos R, Offringa R, et al. (2005) Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene 24: 8338-8342.
46. Ritsma L, Steller EJA, Ellenbroek SIJ, Kranenburg O, Borel Rinkes IHM, et al. (2013) Surgical implantation of an abdominal imaging window for intravital microscopy. Nat Protocols 8: 583-594.